Trade NRSNW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NeuroSense Therapeutics Ltd. Warrant (NRSNW) is trading at US$0.04, down 11.11% today as of Sep 21, 16:00 EDT. Over the past 52 weeks, NRSNW has traded between US$0.04 and US$0.60. On Syfe you can trade NRSNW with $0 commission and add it to your watchlist.
| Previous close | US$0.05 |
|---|---|
| 52-week range | US$0.04 – US$0.60 |
| Volume | 1.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NeuroSense Therapeutics Ltd. Warrant
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
Year: 2021
NeuroSense Therapeutics Ltd. Warrant (NRSNW) stock is trading at US$0.04, -11.11% from the previous close of US$0.05.
The 52-week high for NeuroSense Therapeutics Ltd. Warrant (NRSNW) stock is US$0.60.
The 52-week low for NeuroSense Therapeutics Ltd. Warrant (NRSNW) stock is US$0.04.
NeuroSense Therapeutics Ltd. Warrant (NRSNW) does not currently pay a dividend.
Stay on top of NRSNW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
